PAB 0.00% 0.8¢ patrys limited

Patrys Releases Details of PAT-SM6 & Carfilzomib Clinical Trial

  1. 1,670 Posts.
    An just came out.




    PAT-SM6 to be used in combination with carfilzomib and dexamethasone
    Phase Ib/IIa trial expected to commence end of 2014 and recruitment to take 15-18 months
    To be conducted at two leading University clinics in Germany
 
watchlist Created with Sketch. Add PAB (ASX) to my watchlist
(20min delay)
Last
0.8¢
Change
0.000(0.00%)
Mkt cap ! $16.46M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 30994 0.8¢
 

Sellers (Offers)

Price($) Vol. No.
0.7¢ 30995 1
View Market Depth
Last trade - 09.00am 21/06/2024 (20 minute delay) ?
PAB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.